SARS-CoV-2 JN.1, Animal Human, 2023, JN.1
virus

SARS-CoV-2 JN.1, Animal Human, 2023, JN.1

EVAg
Produced by
: ERASMUS-MC
Shipping From
: Rotterdam - NL

Product Description

Ref-SKU:
010V-05667
Infectious cell culture supernatant containing SARS-CoV-2, JN.1. Isolated from throat/Nasopharynx and cultured on Calu-3 cells. To confirm the identity the virus has been sequenced as well as confirmed to be mycoplasma free.
Product Risk Group: 
RG3
ICTV Taxonomy: 
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus
Virus name: 
SARS-CoV-2 JN.1
Genotype: 
JN.1

Storage conditions: 
Viral Storage Medium -80C
Sequencing: 
Complete genome
Infectivity: 
Infectivity tested
Mycoplasmic content: 
Mycoplasma free

Unit definition: 
1 vial (1mL)

In stock

1 500,00 €
 (Cost per access for Academics)
Free access available

catalogue

biobank

Portal

EVAg

purchase

buy

order

price

cost

shipping

shipment

experiment

research

laboratory

viral

virus

GMO: 
No
Biosafety restrictions: 
Biosafety lab class 3 requierd
Virus host type: 
Animal virus
Human virus
Infectivity Test: 
Infectivity Test: Tissue Culture Infectious Dose (TCID50) determined using titration assay with Spearman-Karber method. Viral titer: 1,24E+08 TCID50/ml
Production cell line: 
Calu-3
Virus Cultivability: 
Cultivable virus
Passage: 
3
Identification technique: 
PCR, sequencing technology (MinION
Technical recommendation: 
Culture conditions: 37°C and 5% CO2. Culture Medium: Advanced DMEM (Dulbecco's Modified Eagle Medium) supplemented with 1% HEPES (1M), 1% GlutaMax (200 mM), 1% Penicilline/Streptomycine (10000 U/ml ; 10000 µg/ml) and 1% Amphotericine B (0.25 mg/ml).
Shipping conditions: 
Dry ice
IATA Classification: 
Category A, UN2814

Information about the collection of the virus

Recombinant product: 
No
Biological material origin: 
Natural origin
Collection date: 
Thursday, 30 November, 2023
Isolation host: 
Human